Bowel Management Systems Market Size, Growth, Trends, Scope and Forecast 2021-2030
Bowel Management Systems Market value reached at US$ 2.1 billion in 2020 and projected to hit US$ 2.9 billion by 2030, expand at a moderate CAGR of 4.1% from 2021 to 2030. North America held a major share of the global bowel management systems market in 2020 due to high healthcare spending, advanced healthcare infrastructure, and high awareness about bowel management devices. The bowel management systems market in Asia Pacific is expected to expand at a high CAGR of 5.1% from 2021 to 2031 due to increase in healthcare expenditure and geriatric population in the region.
Rise in prevalence of fecal incontinence, increase in geriatric population, and surge in acceptance of bowel management products are key factors projected to drive the global bowel management systems market during the forecast period.
Rise in Prevalence of Fecal Incontinence to Drive Market
Fecal incontinence is among the most common pathophysiological medical conditions found in the geriatric population and women, worldwide. Fecal incontinence significantly affects a patient’s quality of life. Bowel management systems play an important role in improving the lifestyles of people suffering from the disorder and making their condition better. The rise in prevalence of fecal incontinence is projected to drive the global bowel management systems market during the forecast period.
An article published by the National Center for Biotechnology Information in 2020 stated that the overall reported prevalence of fecal incontinence ranges from 2% to 21%, with a median of 7.7%.
Systems with Odor-proof Coating, Robust Collection Bag Features Preferred
Manufacturers in the bowel management systems market are increasing their production capabilities in products that offer the possibility to flush the device if needed and take samples via the sampling port. Primed Halberstadt Medizintechnik GmbH - a medical equipment manufacturer is being publicized for its DIARFLEX® ADVANCED stool management system, which can be administered rectally via the irrigation connector. Med-tech companies are taking cues from such innovations to develop systems that provide special odor-proof coating.
Companies are developing bowel management systems with collection bag features such as an additional active carbon filter. An increasing number of companies in the bowel management systems market is realizing the importance of R&D investments to offer a dynamic and comprehensive range of products.
Overview
The report includes an elaborate executive summary, which provides a snapshot of various segments of the global bowel management systems market. It also provides information and data analysis of the bowel management systems market about segments based on product, patient type, end user, and region.
The overview section of the report provides a detailed qualitative analysis of drivers, restraints, and opportunities that impact the global bowel management systems market.
The report includes company profiles, which provide information about their business, product portfolios, and competition landscape in the global bowel management systems market.
The report on the bowel management systems market offers market attractiveness analysis of regions and segments.
The last section of the report comprises quantitative and qualitative analyses on market share/position of key players operating in the global bowel management systems market. It analyzes key competitive strategies adopted by major industry players, thereby presenting a thorough understanding of the competitive scenario in the global bowel management systems market.
Report Highlights
In terms of product, the global bowel management systems market has been bifurcated into systems and accessories. The systems segment dominated the global bowel management systems market in 2020, and the trend is anticipated to continue during the forecast period. The growth of the segment can be attributed to increase in rate of adoption of bowel management systems in emerging markets.
In terms of patient type, the global bowel management systems market has been classified into adult and pediatric. The adult segment held a major share of the global bowel management systems market in 2020. Fecal incontinence is more common in adults due to greater prevalence of neurologic diseases and weaker muscle tone.
Based on end user, the global bowel management systems market has been divided into hospitals, ambulatory surgical centers, and home care settings. The hospitals segment dominated the market in 2020, owing to a large patient base and high adoption of bowel management systems in hospitals.
In terms of region, the global bowel management systems market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is projected to account for a leading share of the global bowel management systems market during the forecast period. High prevalence of fecal incontinence and increase in geriatric population are the major factors driving the market in the region. According to the Population Reference Bureau, the geriatric population in the U.S. is anticipated to double from 52 million in 2018 to 95 million by 2060.
The market in Europe is expected to expand at a high CAGR in the near future, owing to the presence of local as well as global players and an increase in the demand for bowel management systems devices in the region. The bowel management systems market in Asia Pacific is likely to grow at a rapid pace in the near future. Rise in awareness and increase in healthcare expenditure in countries in the region are projected to propel the market in Asia Pacific over the next few years. Japan, India, and China are anticipated to be lucrative markets for bowel management systems during the forecast period.
Key Players
Key players operating in the global bowel management systems market are Axonics, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Coloplast Group, ConvaTec Group, plc, Consure Medical, Hollister Incorporated, Laborie Medical Technologies, Corp., ProSys International Ltd., Renew Medical, Inc., Welland Medical Limited, Qufora A/S, Medtronic, Wellspect HealthCare, and TG Eakin. These companies engage in research & development to develop novel products in order to expand product offerings and customer base. Medtronic received the U.S. FDA approval for its InterStim Micro neurostimulator and InterStim SureScan MRI leads for bladder and bowel control conditions in 2020.
Market Segmentation
Report Scope
The Bowel management systems market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Bowel management systems market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Bowel management systems market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Bowel management systems market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Bowel management systems market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Bowel management systems capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Bowel management systems by regions (countries) and application.
In this study, the years considered to estimate the market size of Bowel management systems are as follows:
Major Key Points Covered in Report:
Executive Summary: It includes key trends of the Bowel management systems market related to products, applications, and other crucial factors. It also provides analysis of the competitive landscape and CAGR and market size of the Bowel management systems market based on production and revenue.
Production and Consumption by Region: It covers all regional markets to which the research study relates. Prices and key players in addition to production and consumption in each regional market are discussed.
Key Players: Here, the report throws light on financial ratios, pricing structure, production cost, gross profit, sales volume, revenue, and gross margin of leading and prominent companies competing in the Bowel management systems market.
Market Segments: This part of the report discusses about product, application and other segments of the Bowel management systems market based on market share, CAGR, market size, and various other factors.
Research Methodology: This section discusses about the research methodology and approach used to prepare the report. It covers data triangulation, market breakdown, market size estimation, and research design and/or programs.
The study objectives of this report are:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Bowel Management Systems Market, By Patient Type
7.1. Bowel Management Systems Market, By Patient Type, 2021-2028
7.1.1. Adult
7.1.1.1. Market Revenue and Forecast (2016-2028)
7.1.2. Pediatric
7.1.2.1. Market Revenue and Forecast (2016-2028)
Chapter 8. Global Bowel Management Systems Market, By Product
8.1. Bowel Management Systems Market, By Product, 2021-2028
8.1.1. Colostomy Bags
8.1.1.1. Market Revenue and Forecast (2016-2028)
8.1.2. Irrigation Systems
8.1.2.1. Market Revenue and Forecast (2016-2028)
8.1.3. Nerve Modulation Devices
8.1.3.1. Market Revenue and Forecast (2016-2028)
Chapter 9. Global Bowel Management Systems Market, By End-use
9.1. Bowel Management Systems Market, By End-use, 2021-2028
9.1.1. Home Care
9.1.1.1. Market Revenue and Forecast (2016-2028)
9.1.2. Hospitals and Ambulatory Surgery Centers
9.1.2.1. Market Revenue and Forecast (2016-2028)
Chapter 10. Global Bowel Management Systems Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, By Patient Type (2016-2028)
10.1.2. Market Revenue and Forecast, By Product (2016-2028)
10.1.3. Market Revenue and Forecast, By End-use (2016-2028)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, By Patient Type (2016-2028)
10.1.4.2. Market Revenue and Forecast, By Product (2016-2028)
10.1.4.3. Market Revenue and Forecast, By End-use (2016-2028)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, By Patient Type (2016-2028)
10.1.5.2. Market Revenue and Forecast, By Product (2016-2028)
10.1.5.3. Market Revenue and Forecast, By End-use (2016-2028)
10.2. Europe
10.2.1. Market Revenue and Forecast, By Patient Type (2016-2028)
10.2.2. Market Revenue and Forecast, By Product (2016-2028)
10.2.3. Market Revenue and Forecast, By End-use (2016-2028)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, By Patient Type (2016-2028)
10.2.4.2. Market Revenue and Forecast, By Product (2016-2028)
10.2.4.3. Market Revenue and Forecast, By End-use (2016-2028)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, By Patient Type (2016-2028)
10.2.5.2. Market Revenue and Forecast, By Product (2016-2028)
10.2.5.3. Market Revenue and Forecast, By End-use (2016-2028)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, By Patient Type (2016-2028)
10.2.6.2. Market Revenue and Forecast, By Product (2016-2028)
10.2.6.3. Market Revenue and Forecast, By End-use (2016-2028)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, By Patient Type (2016-2028)
10.2.7.2. Market Revenue and Forecast, By Product (2016-2028)
10.2.7.3. Market Revenue and Forecast, By End-use (2016-2028)
10.3. APAC
10.3.1. Market Revenue and Forecast, By Patient Type (2016-2028)
10.3.2. Market Revenue and Forecast, By Product (2016-2028)
10.3.3. Market Revenue and Forecast, By End-use (2016-2028)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, By Patient Type (2016-2028)
10.3.4.2. Market Revenue and Forecast, By Product (2016-2028)
10.3.4.3. Market Revenue and Forecast, By End-use (2016-2028)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, By Patient Type (2016-2028)
10.3.5.2. Market Revenue and Forecast, By Product (2016-2028)
10.3.5.3. Market Revenue and Forecast, By End-use (2016-2028)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, By Patient Type (2016-2028)
10.3.6.2. Market Revenue and Forecast, By Product (2016-2028)
10.3.6.3. Market Revenue and Forecast, By End-use (2016-2028)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, By Patient Type (2016-2028)
10.3.7.2. Market Revenue and Forecast, By Product (2016-2028)
10.3.7.3. Market Revenue and Forecast, By End-use (2016-2028)
10.4. MEA
10.4.1. Market Revenue and Forecast, By Patient Type (2016-2028)
10.4.2. Market Revenue and Forecast, By Product (2016-2028)
10.4.3. Market Revenue and Forecast, By End-use (2016-2028)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, By Patient Type (2016-2028)
10.4.4.2. Market Revenue and Forecast, By Product (2016-2028)
10.4.4.3. Market Revenue and Forecast, By End-use (2016-2028)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, By Patient Type (2016-2028)
10.4.5.2. Market Revenue and Forecast, By Product (2016-2028)
10.4.5.3. Market Revenue and Forecast, By End-use (2016-2028)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, By Patient Type (2016-2028)
10.4.6.2. Market Revenue and Forecast, By Product (2016-2028)
10.4.6.3. Market Revenue and Forecast, By End-use (2016-2028)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, By Patient Type (2016-2028)
10.4.7.2. Market Revenue and Forecast, By Product (2016-2028)
10.4.7.3. Market Revenue and Forecast, By End-use (2016-2028)
10.5. Latin America
10.5.1. Market Revenue and Forecast, By Patient Type (2016-2028)
10.5.2. Market Revenue and Forecast, By Product (2016-2028)
10.5.3. Market Revenue and Forecast, By End-use (2016-2028)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, By Patient Type (2016-2028)
10.5.4.2. Market Revenue and Forecast, By Product (2016-2028)
10.5.4.3. Market Revenue and Forecast, By End-use (2016-2028)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, By Patient Type (2016-2028)
10.5.5.2. Market Revenue and Forecast, By Product (2016-2028)
10.5.5.3. Market Revenue and Forecast, By End-use (2016-2028)
Chapter 11. Company Profiles
11.1. Medtronic
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Coloplast
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. 3M
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. B. Braun
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Consure Medical
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. C.R. Bard
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Cogentix Medical
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Axonics Modulation Technologies
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Aquaflush Medical Limited
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. ConvaTec
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. MBH-International A/S
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. Hollister
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. Mederi Therapeutics Inc.
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
11.14. Wellspect HealthCare
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance
11.14.4. Recent Initiatives
11.15. Welland Medical limited
11.15.1. Company Overview
11.15.2. Product Offerings
11.15.3. Financial Performance
11.15.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers